A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy
Clinical trial NCT00283465 · COMPLETED
Trial details
- NCT number
- NCT00283465
- Sponsor
- Janssen-Cilag B.V.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 1999-11-01
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.